Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Kaczorowski

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
International Journal of Oncology|July 15, 2014
Sulforaphane, quercetin and catechins complement each other in elimination of advanced pancreatic cancer by miR-let-7 induction and K-ras inhibitionMahesh Appari, Kamesh R Babu, Adam Kaczorowski, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|November 23, 2017
APOBEC3A Expression in Penile Squamous Cell CarcinomaMartina Heller, Elena-Sophie Prigge, Adam Kaczorowski, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|April 2, 2020
Microenvironment-Derived FGF-2 Stimulates Renal Cell Carcinoma Cell Proliferation through Modulation of p27Kip1: Implications for Spatial Niche Formation and Functional Intratumoral HeterogeneityWeibin Hou, Adam Kaczorowski, Philippa Lantwin, et al.
Urologia Internationalis|April 27, 2022
Interleukin-2 and Interferon-α for Advanced Renal Cell Carcinoma: Patient Outcomes, Sexual Dimorphism of Responses, and Multimodal Treatment Approaches over a 30-Year PeriodEva Bonetti, Maximilian Jenzer, Cathleen Nientiedt, et al.
Cancers|December 23, 2023
Long-Term Survival of Patients with Stage T1N0M1 Renal Cell CarcinomaViktoria Schütz, Huan Lin, Adam Kaczorowski, et al.
Cancer Treatment and Research Communications|July 4, 2020
Antibody selection influences the detection of AR-V7 in primary prostate cancerAdam Kaczorowski, Xin Chen, Esther Herpel, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|April 2, 2023
Senescent Tumor Cells Are Frequently Present at the Invasion Front: Implications for Improving Disease Control in Patients with Locally Advanced Prostate CancerSebastian Schwarz, Cathleen Nientiedt, Elena-Sophie Prigge, et al.
Frontiers in Oncology|May 12, 2025
Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept studyJakob Wieke, Christina Jurcic, Adam Kaczorowski, et al.
Frontiers in Oncology|May 27, 2022
Kidney Cancer Models for Pre-Clinical Drug Discovery: Challenges and OpportunitiesLaura Pohl, Jana Friedhoff, Christina Jurcic, et al.
Cancers|March 6, 2021
<i>miR-449a</i> Repression Leads to Enhanced NOTCH Signaling in <i>TMPRSS2:ERG</i> Fusion Positive Prostate Cancer CellsSimone Bauer, Leonie Ratz, Doreen Heckmann-Nötzel, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
International Journal of Oncology|July 15, 2014
Sulforaphane, quercetin and catechins complement each other in elimination of advanced pancreatic cancer by miR-let-7 induction and K-ras inhibitionMahesh Appari, Kamesh R Babu, Adam Kaczorowski, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|November 23, 2017
APOBEC3A Expression in Penile Squamous Cell CarcinomaMartina Heller, Elena-Sophie Prigge, Adam Kaczorowski, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|April 2, 2020
Microenvironment-Derived FGF-2 Stimulates Renal Cell Carcinoma Cell Proliferation through Modulation of p27Kip1: Implications for Spatial Niche Formation and Functional Intratumoral HeterogeneityWeibin Hou, Adam Kaczorowski, Philippa Lantwin, et al.
Urologia Internationalis|April 27, 2022
Interleukin-2 and Interferon-α for Advanced Renal Cell Carcinoma: Patient Outcomes, Sexual Dimorphism of Responses, and Multimodal Treatment Approaches over a 30-Year PeriodEva Bonetti, Maximilian Jenzer, Cathleen Nientiedt, et al.
Cancers|December 23, 2023
Long-Term Survival of Patients with Stage T1N0M1 Renal Cell CarcinomaViktoria Schütz, Huan Lin, Adam Kaczorowski, et al.
Cancer Treatment and Research Communications|July 4, 2020
Antibody selection influences the detection of AR-V7 in primary prostate cancerAdam Kaczorowski, Xin Chen, Esther Herpel, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|April 2, 2023
Senescent Tumor Cells Are Frequently Present at the Invasion Front: Implications for Improving Disease Control in Patients with Locally Advanced Prostate CancerSebastian Schwarz, Cathleen Nientiedt, Elena-Sophie Prigge, et al.
Frontiers in Oncology|May 12, 2025
Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept studyJakob Wieke, Christina Jurcic, Adam Kaczorowski, et al.
Frontiers in Oncology|May 27, 2022
Kidney Cancer Models for Pre-Clinical Drug Discovery: Challenges and OpportunitiesLaura Pohl, Jana Friedhoff, Christina Jurcic, et al.
Cancers|March 6, 2021
<i>miR-449a</i> Repression Leads to Enhanced NOTCH Signaling in <i>TMPRSS2:ERG</i> Fusion Positive Prostate Cancer CellsSimone Bauer, Leonie Ratz, Doreen Heckmann-Nötzel, et al.
Pageof 3